About Qvella Corporation
Qvella Corporation is a company based in Toronto (Canada) founded in 2009. It operates as a B2B. Qvella Corporation has raised $39.7 million across 3 funding rounds from investors including RA Capital, BioMerieux and Whitecap VP. Qvella Corporation has completed 1 acquisition, including NOVX Systems. Qvella Corporation operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and CytoVale, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$39.7 M (USD)
in 3 rounds
-
Latest Funding Round
$19.7 M (USD), Series B
Dec 03, 2017
-
Investors
RA Capital
& 4 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Qvella Corporation
Unlock access to complete
Funding Insights of Qvella Corporation
Qvella Corporation has successfully raised a total of $39.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $19.7 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Qvella Corporation
Qvella Corporation has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, BioMerieux and Whitecap VP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Whitecap VP is engaged in venture capital investments for startups.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked |
Investor details for Qvella Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qvella Corporation
Qvella Corporation has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NOVX Systems.
Investment portfolio details for Qvella Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Web-based EMR and case management software is provided for healthcare.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Qvella Corporation
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Qvella Corporation
Detailed financials for Qvella Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qvella Corporation Comparisons
Peer comparison for Qvella Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qvella Corporation
Qvella Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and CytoVale, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Microfluidic-based biomarkers for the early detection of sepsis
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
Detailed competitors of Qvella Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qvella Corporation
Complete news archive for Qvella Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qvella Corporation
Qvella Corporation was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Qvella Corporation is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Qvella Corporation is a funded company, having raised a total of $39.7M across 3 funding rounds to date.
Qvella Corporation develops innovative platforms for accurate and rapid bacteria diagnosis in healthcare, focusing on providing healthcare solutions, medical technology, offering diagnostic solutions, and bacteria identification. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Qvella Corporation's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Qvella Corporation has made 1 acquisition, including NOVX Systems.
Qvella Corporation has 5 investors. Key investors include RA Capital, BioMerieux, Whitecap VP, Hatteras Venture Partners, and Sands Capital Ventures.